Latest Period
Q2 2026
Security Snapshot
Pulmonx Corp - Common Stock (LUNG) Institutional Ownership
CUSIP: 745848101
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
108
Shares (Excl. Options)
26,210,091
Price
$1.30
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- LUNG on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 26,210,091
- Total 13F value
- $34,071,820
- Portfolio coverage rank
- 0%
- Share change
- -5,484,237
- Value change
- -$7,119,324
- Number of holders
- 108
- Shares outstanding
- 42,322,333
- SEC-reported price per share
- $2.28
- Insider filing price
- $2.28
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LUNG - Pulmonx Corp - Common Stock is tracked under CUSIP 745848101.
- 108 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 111 to 108 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $40,902,623 to $34,071,820.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 108 institutions filings for Q2 2026.
Security key
745848101
Latest holder period
Q2 2026
13F holders
108
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
LUNG full holder history
Pulmonx Corp SEC filings
Pulmonx Corp company facts
Pulmonx Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 745848101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
LUNG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 12% | -10% | $8,029,839 | -$742,073 | 4,956,691 | -8.5% | PRIMECAP MANAGEMENT CO/CA/ | 30 Sep 2025 |
| MORGAN STANLEY | 6.9% | -18% | $4,292,754 | -$691,629 | 2,920,241 | -14% | Morgan Stanley | 30 Jun 2026 |
| Soleus Capital Master Fund, L.P. | 6.5% | $4,344,113 | 2,665,100 | Soleus Capital Master Fund, L.P. | 06 Mar 2026 | |||
| BlackRock, Inc. | 1.8% | -71% | $995,514 | -$2,508,253 | 765,721 | -72% | BlackRock, Inc. | 30 Jun 2026 |
| FMR LLC | 0.2% | -104% | $114,736 | -$3,416,852 | 70,825 | -97% | FMR LLC | 31 Oct 2025 |
As of 30 Jun 2026, 108 institutional investors reported holding 26,210,091 shares of Pulmonx Corp - Common Stock (LUNG). This represents 62% of the company’s total 42,322,333 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
54%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 11% | 4,612,331 | -2.4% | 0% | $5,996,030 |
| MORGAN STANLEY | 6.9% | 2,922,921 | -27% | 0% | $3,799,797 |
| Soleus Capital Management, L.P. | 6.6% | 2,788,323 | 0% | 0.12% | $3,624,820 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 1,630,219 | -0.25% | 0% | $2,119,285 |
| ExodusPoint Capital Management, LP | 2.9% | 1,223,555 | -37% | 0.01% | $1,590,622 |
| Almitas Capital LLC | 2.5% | 1,064,202 | 0.33% | $1,383,463 | |
| BlackRock, Inc. | 2.1% | 882,490 | -67% | 0% | $1,147,238 |
| Stonepine Capital Management, LLC | 1.9% | 815,436 | +6.1% | 0.81% | $1,060,067 |
| JANE STREET GROUP, LLC | 1.8% | 758,231 | +469% | 0% | $985,700 |
| BRAIDWELL LP | 1.8% | 752,541 | 0% | 0.04% | $978,303 |
| AQR CAPITAL MANAGEMENT LLC | 1.8% | 744,963 | +108% | 0% | $968,453 |
| Parkman Healthcare Partners LLC | 1.5% | 646,564 | -14% | 0.09% | $840,533 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 452,684 | -52% | 0% | $588,714 |
| RENAISSANCE TECHNOLOGIES LLC | 1% | 425,110 | +33% | 0% | $552,643 |
| ADAR1 Capital Management, LLC | 0.96% | 404,497 | +8% | 0.02% | $525,846 |
| DEUTSCHE BANK AG\ | 0.95% | 402,316 | -65% | 0% | $523,011 |
| D. E. Shaw & Co., Inc. | 0.77% | 327,528 | -2.3% | 0% | $425,787 |
| Jefferies Financial Group Inc. | 0.67% | 285,110 | 0% | 0% | $370,643 |
| CFM WEALTH PARTNERS LLC | 0.62% | 264,039 | 0% | 0.04% | $343,251 |
| VANGUARD FIDUCIARY TRUST CO | 0.59% | 250,511 | -11% | 0% | $325,664 |
| MARSHALL WACE, LLP | 0.55% | 230,738 | 0% | $299,959 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.53% | 223,141 | +34% | 0% | $287,000 |
| MILLENNIUM MANAGEMENT LLC | 0.5% | 209,556 | 0% | $272,423 | |
| UBS Group AG | 0.48% | 204,053 | -2.7% | 0% | $265,269 |
| Birchview Capital, LP | 0.47% | 200,543 | -20% | 0.12% | $260,706 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 26,210,091 | $34,071,820 | -$7,119,324 | $1.30 | 108 |
| 2026 Q1 | 31,742,669 | $40,902,623 | -$1,886,778 | $1.29 | 111 |
| 2025 Q4 | 32,396,800 | $71,586,474 | +$3,228,827 | $2.21 | 113 |
| 2025 Q3 | 31,835,122 | $51,571,453 | -$11,678,469 | $1.62 | 104 |
| 2025 Q2 | 36,256,022 | $93,898,311 | -$4,596,833 | $2.59 | 113 |
| 2025 Q1 | 36,156,132 | $243,324,576 | +$1,663,003 | $6.73 | 114 |
| 2024 Q4 | 35,870,967 | $243,565,337 | +$1,640,704 | $6.79 | 117 |
| 2024 Q3 | 35,563,337 | $293,811,542 | +$7,857,689 | $8.29 | 112 |
| 2024 Q2 | 34,744,517 | $220,280,080 | -$2,027,570 | $6.34 | 108 |
| 2024 Q1 | 34,672,382 | $321,430,455 | +$7,599,744 | $9.27 | 117 |
| 2023 Q4 | 33,520,168 | $427,381,569 | +$18,995,295 | $12.75 | 122 |
| 2023 Q3 | 33,253,122 | $343,505,198 | -$6,689,600 | $10.33 | 113 |
| 2023 Q2 | 33,869,172 | $443,992,925 | -$9,642,079 | $13.11 | 112 |
| 2023 Q1 | 34,707,575 | $388,032,205 | +$25,513,692 | $11.18 | 101 |
| 2022 Q4 | 33,773,100 | $284,706,913 | -$83,075,336 | $8.43 | 111 |
| 2022 Q3 | 34,912,391 | $581,637,070 | -$4,909,166 | $16.66 | 100 |
| 2022 Q2 | 35,341,147 | $520,187,047 | -$7,902,826 | $14.72 | 102 |
| 2022 Q1 | 34,711,340 | $861,059,885 | +$56,937,629 | $24.81 | 105 |
| 2021 Q4 | 32,045,807 | $1,027,712,027 | +$25,949,573 | $32.07 | 108 |
| 2021 Q3 | 31,600,475 | $1,136,986,158 | +$204,291,164 | $35.98 | 118 |
| 2021 Q2 | 25,771,799 | $1,136,970,052 | +$216,275,676 | $44.12 | 112 |
| 2021 Q1 | 20,788,776 | $950,879,909 | +$115,760,357 | $45.74 | 107 |
| 2020 Q4 | 17,288,638 | $1,179,671,046 | +$1,018,686,046 | $69.02 | 98 |